Five-year experience using the Lung Allocation Score: the Munich Lung Transplant Group.

Area of Science:

• Pulmonology
• Transplant Surgery
• Medical Informatics

Background:

• The Lung Allocation Score (LAS) was adopted in Germany in 2011, following its successful implementation in the USA.
• Limited data exist on the LAS's impact on German lung transplantation programs.
• This study evaluates the initial 5-year experience with LAS at a single Eurotransplant Foundation center.

Purpose of the Study:

• To analyze the 5-year outcomes of lung transplantation under the LAS system.
• To assess the LAS's effect on patient selection and waiting times.
• To compare transplant outcomes based on diagnosis and LAS scores.

Main Methods:

• Analysis of 294 lung transplant recipients (2012-2016) at a single center.
• Patients categorized by primary diagnosis; Kaplan-Meier survival analysis performed.
• Comparison of waitlist characteristics, transplant procedures, and 5-year post-transplant outcomes.

Main Results:

• Lung transplants for interstitial lung disease increased (27% to 54%), while those for COPD declined (29% to 19%).
• Overall waiting times remained around 200 days; COPD patients comprised an increasing proportion of the waitlist.
• Bilateral sequential lung transplantation showed better long-term survival than single-lung transplantation (P < 0.001).

Conclusions:

• The LAS functions as a robust tool for selecting lung transplant candidates based on urgency and disease-specific benefit.
• The LAS did not lead to a reduction in overall waiting times for lung transplant recipients.
• Further multicenter, long-term studies are needed to evaluate differential transplant center activities and LAS impact.